Coyne Christine 4
4 · Iterum Therapeutics plc · Filed Jul 3, 2025
Insider Transaction Report
Form 4
Coyne Christine
Chief Commercial Officer
Transactions
- Award
Share Option (Right to Buy)
2025-07-01+200,000→ 200,000 totalExercise: $0.97Exp: 2035-06-30→ Ordinary Shares (200,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of July 1, 2025 and the remaining 75% will vest in equal monthly installments thereafter until July 1, 2029, subject to the Reporting Person providing continuous service to the Issuer on each relevant vesting date.